February 17, 2026
Headlines

Expert Outlook: Recursion Pharmaceuticals Through The Eyes Of 4 Analysts

Sumain Faisal01 mins

Latest Ratings for RXRX

Date Firm Action From To
Mar 2022 SVB Leerink Downgrades Outperform Market Perform
Dec 2021 SVB Leerink Maintains Outperform
Sep 2021 Berenberg Initiates Coverage On Buy

View More Analyst Ratings for RXRX

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News